Clark-Curtiss et al., 2018 - Google Patents
Salmonella vaccines: conduits for protective antigensClark-Curtiss et al., 2018
- Document ID
- 9728893571363153934
- Author
- Clark-Curtiss J
- Curtiss III R
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Vaccines afford a better and more cost-effective approach to combatting infectious diseases than continued reliance on antibiotics or antiviral or antiparasite drugs in the current era of increasing incidences of diseases caused by drug-resistant pathogens. Recombinant …
- 229960005486 vaccines 0 title abstract description 112
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clark-Curtiss et al. | Salmonella vaccines: conduits for protective antigens | |
| US11180765B2 (en) | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | |
| Yao et al. | Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip | |
| Garmory et al. | Salmonella vaccines for use in humans: present and future perspectives | |
| US8889121B2 (en) | Bacterium comprising a regulated rfaH nucleic acid | |
| Garmory et al. | The use of live attenuated bacteria as a delivery system for heterologous antigens | |
| Spreng et al. | Rational design of Salmonella-based vaccination strategies | |
| JP4583607B2 (en) | Attenuated microorganisms for the treatment of infectious diseases | |
| Levit et al. | Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health | |
| Wen et al. | Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli | |
| Heine et al. | Shigella IpaB and IpaD displayed on L. lactis bacterium‐like particles induce protective immunity in adult and infant mice | |
| Wang et al. | Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection | |
| US12370248B2 (en) | Attenuated salmonella synthesizing antigens for vaccinating against helicobacter pylori | |
| Wang et al. | Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines | |
| Sun et al. | Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague | |
| US11975061B2 (en) | Protective immunity enhanced Salmonella vaccine (PIESV) against Brucella spp | |
| Atkins et al. | Recombinant Salmonella vaccines for biodefence | |
| Levine et al. | Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as “carrier” vaccines | |
| KR20040101258A (en) | Bacterial spores | |
| Pellissery et al. | Lactic acid bacteria as mucosal delivery vaccine | |
| US20200030431A1 (en) | Vaccines, compositions and methods for use thereof to prevent or reduce severity of cholera | |
| US10226521B2 (en) | Genetically modified Yersinia as vaccines against Yersinia species | |
| Roland et al. | Attenuated Salmonella for oral immunization | |
| Dougan et al. | Live attenuated Salmonella vaccines as carriers of antigens to the secretory and systemic immune systems | |
| Germani et al. | Live-Attenuated Shigella Vaccines. Is Encouraging Good Enough? |